Viking Global Opportunities Portfolio Gp Llc - Net Worth and Insider Trading
Viking Global Opportunities Portfolio Gp Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Viking Global Opportunities Portfolio Gp Llc owns 20 companies in total, including Inhibrx Inc (INBX) , APi Group Corp (APG) , and Zentalis Pharmaceuticals Inc (ZNTL) among others .
Insider Ownership Summary of Viking Global Opportunities Portfolio Gp Llc
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
INBX | Inhibrx Inc | 2022-10-07 | 10 percent owner |
APG | APi Group Corp | 2020-04-28 | 10 percent owner |
ZNTL | Zentalis Pharmaceuticals Inc | 2020-04-03 | 10 percent owner |
![]() | ![]() | 2019-06-26 | 10 percent owner |
![]() | ![]() | 2016-07-08 | 10 percent owner |
![]() | ![]() | 2016-07-08 | 10 percent owner |
![]() | ![]() | 2016-10-26 | 10 percent owner |
![]() | ![]() | 2019-07-10 | other: Former 10% Owner |
![]() | ![]() | 2019-06-27 | 10 percent owner |
![]() | ![]() | 2016-02-02 | 10 percent owner |
![]() | ![]() | 2022-03-18 | 10 percent owner |
![]() | ![]() | 2021-10-01 | 10 percent owner |
![]() | ![]() | 2023-05-09 | 10 percent owner |
![]() | ![]() | 2022-01-06 | 10 percent owner |
![]() | ![]() | 2022-11-15 | 10 percent owner |
![]() | ![]() | 2022-03-02 | 10 percent owner |
![]() | ![]() | 2021-05-26 | 10 percent owner |
![]() | ![]() | 2022-11-01 | 10 percent owner |
![]() | ![]() | 2022-11-01 | 10 percent owner |
![]() | ![]() | 2023-09-14 | 10 percent owner |
Viking Global Opportunities Portfolio Gp Llc Trading Performance
Viking Global Opportunities Portfolio Gp Llc Ownership Network
Ownership Network List of Viking Global Opportunities Portfolio Gp Llc
Ownership Network Relation of Viking Global Opportunities Portfolio Gp Llc

Viking Global Opportunities Portfolio Gp Llc Owned Company Details
What does Inhibrx Inc do?
Who are the key executives at Inhibrx Inc?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of Inhibrx Inc. Other key executives at Inhibrx Inc include director & 10 percent owner & Chief Scientific Officer Brendan P. Eckelman , 10 percent owner Ole Andreas Halvorsen , and 10 percent owner Viking Global Opportunities Parent Gp Llc .
Inhibrx Inc (INBX) Insider Trades Summary
Over the past 18 months, Viking Global Opportunities Portfolio Gp Llc made no insider transaction in Inhibrx Inc (INBX). Other recent insider transactions involving Inhibrx Inc (INBX) include a net sale of 300,000 shares made by Brendan P. Eckelman ,
In summary, during the past 3 months, insiders sold 0 shares of Inhibrx Inc (INBX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 300,000 shares of Inhibrx Inc (INBX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 300,000 shares.
Inhibrx Inc (INBX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inhibrx Inc Insider Transactions
- Download to Excel(.xls)
What does APi Group Corp do?
Who are the key executives at APi Group Corp?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of APi Group Corp. Other key executives at APi Group Corp include See Remarks Louis Lambert , 10 percent owner Viking Global Investors Lp , and Chief Financial Officer Kevin Krumm .
APi Group Corp (APG) Insider Trades Summary
Over the past 18 months, Viking Global Opportunities Portfolio Gp Llc made no insider transaction in APi Group Corp (APG). Other recent insider transactions involving APi Group Corp (APG) include a net sale of 1,000,000 shares made by Ashken Ian G H , a net sale of 22,980,798 shares made by Viking Global Investors Lp , and a net sale of 875,000 shares made by James E Lillie .
In summary, during the past 3 months, insiders sold 157,096 shares of APi Group Corp (APG) in total and bought 0 shares, with a net sale of 157,096 shares. During the past 18 months, 26,860,491 shares of APi Group Corp (APG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 26,860,491 shares.
APi Group Corp (APG)'s detailed insider trading history can be found in Insider Trading Tracker table.
APi Group Corp Insider Transactions
- Download to Excel(.xls)
What does Zentalis Pharmaceuticals Inc do?
Who are the key executives at Zentalis Pharmaceuticals Inc?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of Zentalis Pharmaceuticals Inc. Other key executives at Zentalis Pharmaceuticals Inc include General Counsel Andrea Paul , Chief Financial Officer Melissa B, Epperly , and Chief Medical Officer Carrie Brownstein .
Zentalis Pharmaceuticals Inc (ZNTL) Insider Trades Summary
Over the past 18 months, Viking Global Opportunities Portfolio Gp Llc made no insider transaction in Zentalis Pharmaceuticals Inc (ZNTL). Other recent insider transactions involving Zentalis Pharmaceuticals Inc (ZNTL) include a net sale of 22,322 shares made by Cam Gallagher , a net sale of 20,364 shares made by Mark Lackner , and a net sale of 16,540 shares made by Andrea Paul .
In summary, during the past 3 months, insiders sold 0 shares of Zentalis Pharmaceuticals Inc (ZNTL) in total and bought 21,000 shares, with a net purchase of 21,000 shares. During the past 18 months, 78,042 shares of Zentalis Pharmaceuticals Inc (ZNTL) were sold and 143,700 shares were bought by its insiders, resulting in a net purchase of 65,658 shares.
Zentalis Pharmaceuticals Inc (ZNTL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Zentalis Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Adaptive Biotechnologies Corp do?
Who are the key executives at Adaptive Biotechnologies Corp?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of Adaptive Biotechnologies Corp. Other key executives at Adaptive Biotechnologies Corp include Principal Accounting Officer Kyle Piskel , Chief Scientific Officer Harlan S Robins , and director & CEO and Chairman Chad M Robins .
Adaptive Biotechnologies Corp (ADPT) Insider Trades Summary
Over the past 18 months, Viking Global Opportunities Portfolio Gp Llc made no insider transaction in Adaptive Biotechnologies Corp (ADPT). Other recent insider transactions involving Adaptive Biotechnologies Corp (ADPT) include a net sale of 22,153 shares made by Kyle Piskel , a net sale of 1,023,797 shares made by Chad M Robins , and a net sale of 166,766 shares made by Harlan S Robins .
In summary, during the past 3 months, insiders sold 163,259 shares of Adaptive Biotechnologies Corp (ADPT) in total and bought 0 shares, with a net sale of 163,259 shares. During the past 18 months, 1,630,649 shares of Adaptive Biotechnologies Corp (ADPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,630,649 shares.
Adaptive Biotechnologies Corp (ADPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptive Biotechnologies Corp Insider Transactions
- Download to Excel(.xls)
What does Arbutus Biopharma Corp do?
Who are the key executives at Arbutus Biopharma Corp?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Medical Officer Karen Sims .
Arbutus Biopharma Corp (ABUS) Insider Trades Summary
Over the past 18 months, Viking Global Opportunities Portfolio Gp Llc made no insider transaction in Arbutus Biopharma Corp (ABUS). Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 33,954 shares made by Michael J. Mcelhaugh , a net sale of 31,776 shares made by David C Hastings , and a net sale of 23,706 shares made by Karen Sims .
In summary, during the past 3 months, insiders sold 0 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 119,597 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 119,597 shares.
Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arbutus Biopharma Corp Insider Transactions
- Download to Excel(.xls)
What does Sio Gene Therapies Inc do?
Who are the key executives at Sio Gene Therapies Inc?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of Sio Gene Therapies Inc. Other key executives at Sio Gene Therapies Inc include Chief Commercial Officer Parag V Meswani , Chief Executive Officer Pavan Cheruvu , and 10 percent owner Roivant Sciences Ltd. .
Sio Gene Therapies Inc (SIOX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sio Gene Therapies Inc (SIOX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sio Gene Therapies Inc (SIOX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sio Gene Therapies Inc (SIOX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sio Gene Therapies Inc Insider Transactions
- Download to Excel(.xls)
What does Myovant Sciences Ltd do?
Who are the key executives at Myovant Sciences Ltd?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of Myovant Sciences Ltd. Other key executives at Myovant Sciences Ltd include 10 percent owner Sumitomo Chemical Co., Ltd. , Chief Commercial Officer Lauren Merendino , and General Counsel & Corp. Secy. Matthew Lang .
Myovant Sciences Ltd (MYOV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Myovant Sciences Ltd (MYOV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Myovant Sciences Ltd (MYOV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Myovant Sciences Ltd (MYOV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Myovant Sciences Ltd Insider Transactions
- Download to Excel(.xls)
What does Urovant Sciences Ltd do?
Who are the key executives at Urovant Sciences Ltd?
Viking Global Opportunities Portfolio Gp Llc is the other: Former 10% Owner of Urovant Sciences Ltd. Other key executives at Urovant Sciences Ltd include SVP & Commercial & USI Walt Johnston , CMO/Urovant Sciences & Inc. Haag-molkenteller Cornelia , and PFO;CFO/Urovant Sciences & Inc. Ajay Bansal .
Urovant Sciences Ltd (UROV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Urovant Sciences Ltd (UROV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Urovant Sciences Ltd (UROV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Urovant Sciences Ltd (UROV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Urovant Sciences Ltd Insider Transactions
- Download to Excel(.xls)
What does BridgeBio Pharma Inc do?
Who are the key executives at BridgeBio Pharma Inc?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of BridgeBio Pharma Inc. Other key executives at BridgeBio Pharma Inc include director & See Remarks Neil Kumar , 10 percent owner Kkr Genetic Disorder L.p. , and See Remarks Brian C Stephenson .
BridgeBio Pharma Inc (BBIO) Insider Trades Summary
Over the past 18 months, Viking Global Opportunities Portfolio Gp Llc made no insider transaction in BridgeBio Pharma Inc (BBIO). Other recent insider transactions involving BridgeBio Pharma Inc (BBIO) include a net sale of 1,012,477 shares made by Neil Kumar , a net sale of 88,959 shares made by Brian C Stephenson , and a net sale of 17,800,000 shares made by Kkr Genetic Disorder L.p. .
In summary, during the past 3 months, insiders sold 6,392,182 shares of BridgeBio Pharma Inc (BBIO) in total and bought 0 shares, with a net sale of 6,392,182 shares. During the past 18 months, 22,233,783 shares of BridgeBio Pharma Inc (BBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 22,233,783 shares.
BridgeBio Pharma Inc (BBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
BridgeBio Pharma Inc Insider Transactions
- Download to Excel(.xls)
What does Editas Medicine Inc do?
Who are the key executives at Editas Medicine Inc?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of Editas Medicine Inc. Other key executives at Editas Medicine Inc include EVP & CHIEF SCIENTIFIC OFFICER Linda Burkly , director & CEO Gilmore Neil O'neill , and EVP & CHIEF FINANCIAL OFFICER Erick Lucera .
Editas Medicine Inc (EDIT) Insider Trades Summary
Over the past 18 months, Viking Global Opportunities Portfolio Gp Llc made no insider transaction in Editas Medicine Inc (EDIT). Other recent insider transactions involving Editas Medicine Inc (EDIT) include a net sale of 125,012 shares made by Gilmore Neil O'neill , a net sale of 28,516 shares made by Baisong Mei , and a net sale of 15,503 shares made by Linda Burkly .
In summary, during the past 3 months, insiders sold 16,364 shares of Editas Medicine Inc (EDIT) in total and bought 0 shares, with a net sale of 16,364 shares. During the past 18 months, 195,923 shares of Editas Medicine Inc (EDIT) were sold and 45,000 shares were bought by its insiders, resulting in a net sale of 150,923 shares.
Editas Medicine Inc (EDIT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Editas Medicine Inc Insider Transactions
- Download to Excel(.xls)
What does PROCEPT BioRobotics Corp do?
Who are the key executives at PROCEPT BioRobotics Corp?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of PROCEPT BioRobotics Corp. Other key executives at PROCEPT BioRobotics Corp include SVP & Commercial Operations Hisham Shiblaq , director & 10 percent owner Antal Rohit Desai , and SVP & GEN COUNSEL & CORP. SEC. Alaleh Nouri .
PROCEPT BioRobotics Corp (PRCT) Insider Trades Summary
Over the past 18 months, Viking Global Opportunities Portfolio Gp Llc made no insider transaction in PROCEPT BioRobotics Corp (PRCT). Other recent insider transactions involving PROCEPT BioRobotics Corp (PRCT) include a net sale of 199,559 shares made by Kevin Waters , a net sale of 126,671 shares made by Alaleh Nouri , and a net sale of 430,105 shares made by Reza Zadno .
In summary, during the past 3 months, insiders sold 101,771 shares of PROCEPT BioRobotics Corp (PRCT) in total and bought 0 shares, with a net sale of 101,771 shares. During the past 18 months, 1,245,441 shares of PROCEPT BioRobotics Corp (PRCT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,245,441 shares.
PROCEPT BioRobotics Corp (PRCT)'s detailed insider trading history can be found in Insider Trading Tracker table.
PROCEPT BioRobotics Corp Insider Transactions
- Download to Excel(.xls)
What does Roivant Sciences Ltd do?
Who are the key executives at Roivant Sciences Ltd?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of Roivant Sciences Ltd. Other key executives at Roivant Sciences Ltd include President & COO Eric Venker , Chief Accounting Officer Rakhi Kumar , and See Remarks Mayukh Sukhatme .
Roivant Sciences Ltd (ROIV) Insider Trades Summary
Over the past 18 months, Viking Global Opportunities Portfolio Gp Llc made no insider transaction in Roivant Sciences Ltd (ROIV). Other recent insider transactions involving Roivant Sciences Ltd (ROIV) include a net sale of 3,336,979 shares made by Eric Venker , a net sale of 1,647,189 shares made by Vivek Ramaswamy , and a net sale of 1,298,821 shares made by Mayukh Sukhatme .
In summary, during the past 3 months, insiders sold 3,597,189 shares of Roivant Sciences Ltd (ROIV) in total and bought 0 shares, with a net sale of 3,597,189 shares. During the past 18 months, 14,598,746 shares of Roivant Sciences Ltd (ROIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 14,598,746 shares.
Roivant Sciences Ltd (ROIV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Roivant Sciences Ltd Insider Transactions
- Download to Excel(.xls)
What does 4D Molecular Therapeutics Inc do?
Who are the key executives at 4D Molecular Therapeutics Inc?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of 4D Molecular Therapeutics Inc. Other key executives at 4D Molecular Therapeutics Inc include Chief Legal and HR Officer Scott Bizily , director & Chief Executive Officer David Kirn , and Chief Medical Officer Robert Young Kim .
4D Molecular Therapeutics Inc (FDMT) Insider Trades Summary
Over the past 18 months, Viking Global Opportunities Portfolio Gp Llc made no insider transaction in 4D Molecular Therapeutics Inc (FDMT). Other recent insider transactions involving 4D Molecular Therapeutics Inc (FDMT) include a net sale of 39,883 shares made by Scott Bizily , a net sale of 225,853 shares made by David Kirn , and a net sale of 540,000 shares made by Viking Global Investors Lp .
In summary, during the past 3 months, insiders sold 0 shares of 4D Molecular Therapeutics Inc (FDMT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 830,288 shares of 4D Molecular Therapeutics Inc (FDMT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 830,288 shares.
4D Molecular Therapeutics Inc (FDMT)'s detailed insider trading history can be found in Insider Trading Tracker table.
4D Molecular Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Amylyx Pharmaceuticals Inc do?
Who are the key executives at Amylyx Pharmaceuticals Inc?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of Amylyx Pharmaceuticals Inc. Other key executives at Amylyx Pharmaceuticals Inc include director & Co-Chief Executive Officer Joshua B Cohen , director & Co-Chief Executive Officer Justin B. Klee , and Chief Financial Officer James M Frates .
Amylyx Pharmaceuticals Inc (AMLX) Insider Trades Summary
Over the past 18 months, Viking Global Opportunities Portfolio Gp Llc made no insider transaction in Amylyx Pharmaceuticals Inc (AMLX). Other recent insider transactions involving Amylyx Pharmaceuticals Inc (AMLX) include a net sale of 42,192 shares made by Gina Mazzariello , a net sale of 73,976 shares made by Justin B. Klee , and a net sale of 73,972 shares made by Joshua B Cohen .
In summary, during the past 3 months, insiders sold 75,493 shares of Amylyx Pharmaceuticals Inc (AMLX) in total and bought 10,000 shares, with a net sale of 65,493 shares. During the past 18 months, 237,644 shares of Amylyx Pharmaceuticals Inc (AMLX) were sold and 209,000 shares were bought by its insiders, resulting in a net sale of 28,644 shares.
Amylyx Pharmaceuticals Inc (AMLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Amylyx Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Rallybio Corp do?
Who are the key executives at Rallybio Corp?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of Rallybio Corp. Other key executives at Rallybio Corp include 10 percent owner 5am Partners V, Llc , director & 10 percent owner Kush Parmar , and See Remarks Jonathan I Lieber .
Rallybio Corp (RLYB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Rallybio Corp (RLYB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Rallybio Corp (RLYB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Rallybio Corp (RLYB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rallybio Corp Insider Transactions
- Download to Excel(.xls)
What does Ginkgo Bioworks Holdings Inc do?
Who are the key executives at Ginkgo Bioworks Holdings Inc?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of Ginkgo Bioworks Holdings Inc. Other key executives at Ginkgo Bioworks Holdings Inc include Chief Accounting Officer Steven P. Coen , Chief Financial Officer Mark E. Dmytruk , and director & CEO & Chairman Harry Sloan .
Ginkgo Bioworks Holdings Inc (DNA) Insider Trades Summary
Over the past 18 months, Viking Global Opportunities Portfolio Gp Llc made no insider transaction in Ginkgo Bioworks Holdings Inc (DNA). Other recent insider transactions involving Ginkgo Bioworks Holdings Inc (DNA) include a net sale of 393,312 shares made by Mark E. Dmytruk , a net sale of 180,088 shares made by Steven P. Coen , and a net sale of 600,000 shares made by Jason R Kelly .
In summary, during the past 3 months, insiders sold 3,293 shares of Ginkgo Bioworks Holdings Inc (DNA) in total and bought 0 shares, with a net sale of 3,293 shares. During the past 18 months, 98,627 shares of Ginkgo Bioworks Holdings Inc (DNA) were sold and 23,065 shares were bought by its insiders, resulting in a net sale of 75,561 shares.
Ginkgo Bioworks Holdings Inc (DNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ginkgo Bioworks Holdings Inc Insider Transactions
- Download to Excel(.xls)
What does FIGS Inc do?
Who are the key executives at FIGS Inc?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of FIGS Inc. Other key executives at FIGS Inc include director & 10 percent owner & Co-Chief Executive Officer Heather L. Hasson , Chief Financial Officer Daniella Turenshine , and director & 10 percent owner & Co-Chief Executive Officer Catherine Eva Spear .
FIGS Inc (FIGS) Insider Trades Summary
Over the past 18 months, Viking Global Opportunities Portfolio Gp Llc made no insider transaction in FIGS Inc (FIGS). Other recent insider transactions involving FIGS Inc (FIGS) include a net sale of 176,526 shares made by Heather L. Hasson , a net sale of 24,164 shares made by Daniella Turenshine , and a net sale of 1,478 shares made by .
In summary, during the past 3 months, insiders sold 1,961 shares of FIGS Inc (FIGS) in total and bought 0 shares, with a net sale of 1,961 shares. During the past 18 months, 202,168 shares of FIGS Inc (FIGS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 202,168 shares.
FIGS Inc (FIGS)'s detailed insider trading history can be found in Insider Trading Tracker table.
FIGS Inc Insider Transactions
- Download to Excel(.xls)
What does Frazier Lifesciences Acquisition Corp do?
Who are the key executives at Frazier Lifesciences Acquisition Corp?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of Frazier Lifesciences Acquisition Corp. Other key executives at Frazier Lifesciences Acquisition Corp include director & Chief Financial Officer David Joseph Topper , 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) , and 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. .
Frazier Lifesciences Acquisition Corp (FLAC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Frazier Lifesciences Acquisition Corp (FLAC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Frazier Lifesciences Acquisition Corp (FLAC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Frazier Lifesciences Acquisition Corp (FLAC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Frazier Lifesciences Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does Frazier Lifesciences Acquisition Corp do?
Who are the key executives at Frazier Lifesciences Acquisition Corp?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of Frazier Lifesciences Acquisition Corp. Other key executives at Frazier Lifesciences Acquisition Corp include director & Chief Financial Officer David Joseph Topper , 10 percent owner & other: Possible Member of 10% Group Deerfield Management Company, L.p. (series C) , and 10 percent owner & other: Possible Member of 10% Group Deerfield Mgmt L.p. .
Frazier Lifesciences Acquisition Corp (FLACU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Frazier Lifesciences Acquisition Corp (FLACU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Frazier Lifesciences Acquisition Corp (FLACU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Frazier Lifesciences Acquisition Corp (FLACU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Frazier Lifesciences Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does RayzeBio inc do?
Who are the key executives at RayzeBio inc?
Viking Global Opportunities Portfolio Gp Llc is the 10 percent owner of RayzeBio inc. Other key executives at RayzeBio inc include 10 percent owner Viking Global Investors Lp , 10 percent owner Viking Global Opportunities Drawdown (aggregator) Lp , and 10 percent owner Goodman Corey S .
RayzeBio inc (RYZB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of RayzeBio inc (RYZB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of RayzeBio inc (RYZB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
RayzeBio inc (RYZB)'s detailed insider trading history can be found in Insider Trading Tracker table.
RayzeBio inc Insider Transactions
- Download to Excel(.xls)
Viking Global Opportunities Portfolio Gp Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Viking Global Opportunities Portfolio Gp Llc. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Viking Global Opportunities Portfolio Gp Llc's mailing address is: Stamford Ct 06901.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey